Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial

Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.
    Difference
    0.7%
    Check dated 2025-07-04T04:15:22.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.6%
    Check dated 2025-06-19T20:07:43.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:25:54.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1.0%
    Check dated 2025-05-29T06:13:07.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T19:24:09.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes in its content regarding a clinical trial for glioblastoma, including the removal of specific details about the investigational medicinal product, losartan, and its study design, while adding a new revision number and the term 'glioblastoma'.
    Difference
    25%
    Check dated 2025-04-16T13:18:02.000Z thumbnail image

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.